43 results on '"Podszywalow-Bartnicka, Paulina"'
Search Results
2. TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment
3. Multiple roles for AU-rich RNA binding proteins in the development of haematologic malignancies and their resistance to chemotherapy
4. TGFβR-SMAD3 Signaling Induces Resistance to PARP Inhibitors in the Bone Marrow Microenvironment
5. Abstract P09: Splicing and translation in chronic myeloid leukemia cells adapting to bone marrow microenvironment and chemotherapy
6. Targeting of Post-Transcriptional Regulation as Treatment Strategy in Acute Leukemia
7. Tyrosine kinase inhibitor–induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors
8. Splicing under stress: A matter of time and place
9. Stress granules assembly affects detection of mRNA in living cells by the NanoFlares; an important aspect of the technology
10. Insight into the Leukemia Microenvironment and Cell-cell Interactions Using Flow Cytometry
11. Supplementary Figures from IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors
12. Data from IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors
13. Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells
14. Abstract 2642: Nascent proteome of leukemia cells in the hypoxic bone marrow microenvironment – role of TIAR and FMRP
15. DNA polymerase theta protects leukemia cells from metabolic-induced DNA damage
16. Hyperglycaemia modifies energy metabolism and reactive oxygen species formation in endothelial cells in vitro
17. TIAR and FMRP Shape Pro-Survival Nascent Proteome of Leukemia Cells in the Bone Marrow Microenvironment
18. Increased acetylation of lysine 317/320 of p53 caused by BCR-ABL protects from cytoplasmic translocation of p53 and mitochondria-dependent apoptosis in response to DNA damage
19. Influence of hypoxia on the RNA binding proteins complexes and translation in leukemia cells
20. The role of intracellular cAMP in renal gluconeogenesis in view of differential action of various cAMP analogues
21. Targeting of Post-Transcriptional Regulation as Treatment Strategy in Acute Leukemia
22. PARP1 Inhibitors Eliminated Imatinib-Refractory Chronic Myeloid Leukemia Cells in Bone Marrow Microenvironment Conditions
23. Characteristics of live parameters of the HS-5 human bone marrow stromal cell line cocultured with the leukemia cells in hypoxia, for the studies of leukemia-stroma cross-talk
24. PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions
25. IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors
26. IGH/MYC Translocation in Burkitt Lymphoma Is Associated with BRCA2 Deficiency and Synthetic Lethality By PARP1 Inhibitors
27. Increased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes
28. Interaction of plasma membrane Ca2+-ATPase isoform 4 with calcineurin A: Implications for catecholamine secretion by PC12 cells
29. Tyrosine Kinase Inhibitor-Induced Defects in DNA Repair Sensitize FLT3(ITD)-Positive Acute Myeloid Leukemia Quiescent and Proliferative Cells to PARP Inhibitors
30. Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells
31. Downregulation of BRCA1 Protein in BCR-ABL1–positive Cells Depends on Tiar-Mediated Repression of BRCA1 mRNA Translation
32. Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation
33. Stimulators of Mineralization Limit the Invasive Phenotype of Human Osteosarcoma Cells by a Mechanism Involving Impaired Invadopodia Formation
34. Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
35. NFAT1 and NFAT3 Cooperate with HDAC4 during Regulation of Alternative Splicing of PMCA Isoforms in PC12 Cells
36. The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
37. PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.
38. Role of annexin A6 isoforms in catecholamine secretion by PC12 cells: Distinct influence on calcium response
39. Expression of Oncogenic Kinase Bcr-Abl Impairs Mitotic Checkpoint and Promotes Aberrant Divisions and Resistance to Microtubule-Targeting Agents
40. Calcium- and pH-dependent localization of annexin A6 isoforms in Balb/3T3 fibroblasts reflecting their potential participation in vesicular transport
41. Calcium- and proton-dependent relocation of annexin A6 in Jurkat T cells stimulated for interleukin-2 secretion.
42. IGH/MYCTranslocation in Burkitt Lymphoma Is Associated with BRCA2 Deficiency and Synthetic Lethality By PARP1 Inhibitors
43. DNA polymerase theta-mediated DNA repair is a functional dependency and therapeutic vulnerability in DNMT3A deficient leukemia cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.